T

TOT BIOPHARM International Co Ltd
HKEX:1875

Watchlist Manager
TOT BIOPHARM International Co Ltd
HKEX:1875
Watchlist
Price: 2.5 HKD Market Closed
Market Cap: 1.9B HKD

Wall Street
Price Targets

Price Targets Summary
TOT BIOPHARM International Co Ltd

There are no price targets for TOT BIOPHARM International Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
TOT BIOPHARM International Co Ltd Competitors:
Price Targets
688177
Bio-Thera Solutions Ltd
50% Upside
2171
CARsgen Therapeutics Holdings Ltd
41% Upside
ABBV
Abbvie Inc
11% Upside
MRSN
Mersana Therapeutics Inc
16% Upside
302440
SK Bioscience Co Ltd
17% Downside
206650
EuBiologics Co Ltd
70% Upside
1530
3SBio Inc
40% Upside
GNS
Genus PLC
15% Upside

Revenue
Forecast

Revenue Estimate
TOT BIOPHARM International Co Ltd

For the last 6 years the compound annual growth rate for TOT BIOPHARM International Co Ltd's revenue is 74%. The projected CAGR for the next 2 years is 22%.

74%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
TOT BIOPHARM International Co Ltd

The compound annual growth rate of TOT BIOPHARM International Co Ltd's operating income for the next 2 years is 104%.

N/A
Past Growth
104%
Estimated Growth
Estimates Accuracy
-43%
Average Miss

Net Income
Forecast

Net Income Estimate
TOT BIOPHARM International Co Ltd

The compound annual growth rate of TOT BIOPHARM International Co Ltd's net income for the next 2 years is 102%.

N/A
Past Growth
102%
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TOT BIOPHARM International Co Ltd's stock price target?
Not Available

TOT BIOPHARM International Co Ltd doesn't have any price targets made by Wall Street professionals.

What is TOT BIOPHARM International Co Ltd's Revenue forecast?
Projected CAGR
22%

For the last 6 years the compound annual growth rate for TOT BIOPHARM International Co Ltd's revenue is 74%. The projected CAGR for the next 2 years is 22%.

What is TOT BIOPHARM International Co Ltd's Operating Income forecast?
Projected CAGR
104%

The compound annual growth rate of TOT BIOPHARM International Co Ltd's operating income for the next 2 years is 104%.

What is TOT BIOPHARM International Co Ltd's Net Income forecast?
Projected CAGR
102%

The compound annual growth rate of TOT BIOPHARM International Co Ltd's net income for the next 2 years is 102%.

Back to Top